231 related articles for article (PubMed ID: 30673299)
21. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
22. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
Aslan Ö; Oktay A; Eroğlu F
Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
[TBL] [Abstract][Full Text] [Related]
23. Management of Non-Mass Enhancement at Breast Magnetic Resonance in Screening Settings Referred for Magnetic Resonance-Guided Biopsy.
de Faria Castro Fleury E; Castro C; do Amaral MSC; Roveda Junior D
Breast Cancer (Auckl); 2022; 16():11782234221095897. PubMed ID: 35602239
[TBL] [Abstract][Full Text] [Related]
24. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement.
Tozaki M; Igarashi T; Fukuda K
AJR Am J Roentgenol; 2006 Aug; 187(2):313-21. PubMed ID: 16861532
[TBL] [Abstract][Full Text] [Related]
25. Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography?
Kamal RM; Helal MH; Mansour SM; Haggag MA; Nada OM; Farahat IG; Alieldin NH
Br J Radiol; 2016 Aug; 89(1064):20160157. PubMed ID: 27327403
[TBL] [Abstract][Full Text] [Related]
26. Association of Different MRI BIRADS Descriptors With Malignancy in Non Mass-Like Breast Lesions.
Gity M; Ghazi Moghadam K; Jalali AH; Shakiba M
Iran Red Crescent Med J; 2014 Dec; 16(12):e26040. PubMed ID: 25763248
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of MRI-Directed Breast Ultrasound and Lesion Characteristics Affecting Visualization on Breast Ultrasound.
Xiao L; Simmons C; Khanani S
Curr Probl Diagn Radiol; 2022; 51(5):717-721. PubMed ID: 35272882
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of mammography for accompanying non-mass enhancement on preoperative breast MRI.
Kim Y; Jung HK; Park AY; Ko KH; Jang H
Acta Radiol; 2022 Aug; 63(8):1032-1042. PubMed ID: 34260322
[TBL] [Abstract][Full Text] [Related]
29. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
30. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
[TBL] [Abstract][Full Text] [Related]
31. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
[TBL] [Abstract][Full Text] [Related]
32. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
[TBL] [Abstract][Full Text] [Related]
33. Non-mass enhancement breast lesions: MRI findings and associations with malignancy.
Liu G; Li Y; Chen SL; Chen Q
Ann Transl Med; 2022 Mar; 10(6):357. PubMed ID: 35433999
[TBL] [Abstract][Full Text] [Related]
34. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).
Tsuchiya K; Mori N; Schacht DV; Sheth D; Karczmar GS; Newstead GM; Abe H
J Magn Reson Imaging; 2017 Dec; 46(6):1738-1747. PubMed ID: 28295791
[TBL] [Abstract][Full Text] [Related]
35. Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy.
Taşkın F; Soyder A; Tanyeri A; Öztürk VS; Ünsal A
Diagn Interv Radiol; 2017; 23(5):333-338. PubMed ID: 28830847
[TBL] [Abstract][Full Text] [Related]
36. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
[TBL] [Abstract][Full Text] [Related]
37. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
[TBL] [Abstract][Full Text] [Related]
38. False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features.
Alikhassi A; Li X; Au F; Kulkarni S; Ghai S; Allison G; Freitas V
Breast Cancer Res Treat; 2023 Apr; 198(2):321-334. PubMed ID: 36740611
[TBL] [Abstract][Full Text] [Related]
39. Grading System to Categorize Breast MRI in BI-RADS 5th Edition: A Multivariate Study of Breast Mass Descriptors in Terms of Probability of Malignancy.
Fujiwara K; Yamada T; Kanemaki Y; Okamoto S; Kojima Y; Tsugawa K; Nakajima Y
AJR Am J Roentgenol; 2018 Mar; 210(3):W118-W127. PubMed ID: 29381382
[TBL] [Abstract][Full Text] [Related]
40. Breast MR biopsy: Pathological and radiological correlation.
Dratwa C; Jalaguier-Coudray A; Thomassin-Piana J; Gonin J; Chopier J; Antoine M; Trop I; Darai E; Thomassin-Naggara I
Eur Radiol; 2016 Aug; 26(8):2510-9. PubMed ID: 26511630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
